Additional Information

Description

Clopidogrel 75 mg is an antiplatelet medication that helps prevent blood clots by inhibiting platelet aggregation. It works by irreversibly blocking the adenosine diphosphate (ADP) receptor on platelets, thus preventing the activation of the glycoprotein IIb/IIIa complex, which is crucial for platelet aggregation. This action reduces the risk of thrombotic events such as stroke, myocardial infarction, and peripheral artery disease.

The primary indication for Clopidogrel 75 mg is the prevention of atherothrombotic events in patients with a history of myocardial infarction, stroke, or established peripheral vascular disease. It is often prescribed for use in combination with aspirin in patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).

Clopidogrel 75 mg tablets are typically taken orally, once daily, with or without food. Common side effects include bleeding, bruising, and gastrointestinal disturbances such as nausea or diarrhea. It is important to monitor for signs of bleeding or bruising and consult a healthcare provider if these occur.